News
How busy has the past month been for 2025 San Diego Music Awards Lifetime Achievement honoree Nathan East, whose 2,000-plus recording credits include albums with such varied artists as B.B. King, ...
It’s a neutral space. You won’t find the president there. Ruth Bass is an award-winning journalist. Her website is ruthbass.com. The opinions expressed by columnists do not necessarily reflect the ...
"We’ve been so very lucky to have had the Ace of Bass in our lives. We know that Dave would have wanted nothing more than to step onstage with us again in Portland on our farewell US tour.
As he began, Hahn clarified that a more fitting title would be “Veritas: The Saving Truth and Humility of God’s Word.” Hahn began by tracing Harvard’s history of “Veritas,” from its ...
The author with a striped bass hooked on a prior fishing trip. Striper fishermen Roger Zalucky, left, of Troy, and Jack Whitman of Colonie both hook into fish while wading the Hudson River Friday ...
Call God, as Johni Broome likes to say. Let the Big Guy know that Auburn’s All-Everything legend not only deserves National Player of the Year after his Elite Eight heroics, but a statue next to ...
THE WOODLANDS, Texas — A Houston-area pharmaceutical company has struck a billion-dollar deal with the seller of Ozempic for a potential drug also aiming to combat obesity. Lexicon ...
The city has already turned over many of the exchanges between Mayor Karen Bass and other officials sought by Times reporters. But officials have argued they are not compelled to do so under state ...
Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) climbed ~95% in the premarket trading on Friday after the Texas-based biotech announced an exclusive license agreement with Novo Nordisk (NVO ...
Novo Nordisk has signed a deal worth up to $1bn with Lexicon Pharmaceuticals for the exclusive global rights to LX9851, an experimental oral treatment for obesity and related metabolic disorders.
Besides fighting strange creatures and filling out a map, Inayah - Life After Gods brings its own ideas to the table. I ran into some gnarly issues along the way, but Inayah’s combat system ...
March 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is licensing Lexicon Pharmaceuticals' (LXRX.O), opens new tab experimental obesity drug in a deal worth up to $1 billion, the Danish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results